BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 32888905)

  • 1. Saliva is a reliable, non-invasive specimen for SARS-CoV-2 detection.
    Vaz SN; Santana DS; Netto EM; Pedroso C; Wang WK; Santos FDA; Brites C
    Braz J Infect Dis; 2020; 24(5):422-427. PubMed ID: 32888905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.
    Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S
    Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of SARS-CoV-2 RNA and Antibodies in Diverse Samples: Protocol to Validate the Sufficiency of Provider-Observed, Home-Collected Blood, Saliva, and Oropharyngeal Samples.
    Sullivan PS; Sailey C; Guest JL; Guarner J; Kelley C; Siegler AJ; Valentine-Graves M; Gravens L; Del Rio C; Sanchez TH
    JMIR Public Health Surveill; 2020 Apr; 6(2):e19054. PubMed ID: 32310815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19.
    Sakanashi D; Asai N; Nakamura A; Miyazaki N; Kawamoto Y; Ohno T; Yamada A; Koita I; Suematsu H; Hagihara M; Shiota A; Kurumiya A; Sakata M; Kato S; Muramatsu Y; Koizumi Y; Kishino T; Ohashi W; Yamagishi Y; Mikamo H
    J Infect Chemother; 2021 Jan; 27(1):126-129. PubMed ID: 33060046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test.
    Sun Q; Li J; Ren H; Pastor L; Loginova Y; Madej R; Taylor K; Wong JK; Zhang Z; Zhang A; Lu CM; Sha MY
    PLoS One; 2021; 16(2):e0243183. PubMed ID: 33621263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saliva-based PCR tests for SARS-CoV-2 detection.
    Takeuchi Y; Furuchi M; Kamimoto A; Honda K; Matsumura H; Kobayashi R
    J Oral Sci; 2020; 62(3):350-351. PubMed ID: 32581183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2.
    Chen JH; Yip CC; Poon RW; Chan KH; Cheng VC; Hung IF; Chan JF; Yuen KY; To KK
    Emerg Microbes Infect; 2020 Dec; 9(1):1356-1359. PubMed ID: 32459137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gargle lavage as a viable alternative to swab for detection of SARS-CoV-2.
    Mittal A; Gupta A; Kumar S; Surjit M; Singh B; Soneja M; Soni KD; Khan AR; Singh K; Naik S; Kumar A; Aggarwal R; Nischal N; Sinha S; Trikha A; Wig N
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):77-81. PubMed ID: 32820725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in use of saliva for detection of SARS CoV-2 RNA in symptomatic outpatients.
    Landry ML; Criscuolo J; Peaper DR
    J Clin Virol; 2020 Sep; 130():104567. PubMed ID: 32750665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of saliva and nasopharyngeal swab for SARS-CoV-2 detection using RT-qPCR among COVID-19 suspected patients at Jigjiga, Eastern Ethiopia.
    Tahir B; Weldegebreal F; Ayele F; Ayana DA
    PLoS One; 2023; 18(3):e0282976. PubMed ID: 36913377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitability and Sufficiency of Telehealth Clinician-Observed, Participant-Collected Samples for SARS-CoV-2 Testing: The iCollect Cohort Pilot Study.
    Guest JL; Sullivan PS; Valentine-Graves M; Valencia R; Adam E; Luisi N; Nakano M; Guarner J; Del Rio C; Sailey C; Goedecke Z; Siegler AJ; Sanchez TH
    JMIR Public Health Surveill; 2020 Jun; 6(2):e19731. PubMed ID: 32479412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic Patients.
    Procop GW; Shrestha NK; Vogel S; Van Sickle K; Harrington S; Rhoads DD; Rubin BP; Terpeluk P
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32883744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru.
    Calderón RI; Jhaveri TA; Tovar MA; Palomino JS; Barreda NN; Sanabria OM; Peinado J; Ramirez C; Llanos Zavalaga LF; Valderrama G; Franke MF; Mitnick CD; Lecca L; Velásquez GE
    Microbiol Spectr; 2022 Aug; 10(4):e0086122. PubMed ID: 35867471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of swab types and collection time on SARS-COV-2 detection using RT-PCR assay.
    Liu M; Li Q; Zhou J; Ai W; Zheng X; Zeng J; Liu Y; Xiang X; Guo R; Li X; Wu X; Xu H; Jiang L; Zhang H; Chen J; Tian L; Luo J; Luo C
    J Virol Methods; 2020 Dec; 286():113974. PubMed ID: 32949663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saliva as a Potential Diagnostic Specimen for COVID-19 Testing.
    Harikrishnan P
    J Craniofac Surg; 2020 Sep; 31(6):e653-e655. PubMed ID: 32541273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR.
    Tsujimoto Y; Terada J; Kimura M; Moriya A; Motohashi A; Izumi S; Kawajiri K; Hakkaku K; Morishita M; Saito S; Takumida H; Watanabe H; Tsukada A; Morita C; Yamaguchi Y; Katsuno T; Kusaba Y; Sakamoto K; Hashimoto M; Suzuki M; Takasaki J; Hojo M; Miyoshi-Akiyama T; Sugiyama H
    Infect Dis (Lond); 2021 Aug; 53(8):581-589. PubMed ID: 33760699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral Load Kinetics of SARS-CoV-2 Infection in Saliva in Korean Patients: a Prospective Multi-center Comparative Study.
    Kim SE; Lee JY; Lee A; Kim S; Park KH; Jung SI; Kang SJ; Oh TH; Kim UJ; Lee SY; Kee SJ; Jang HC
    J Korean Med Sci; 2020 Aug; 35(31):e287. PubMed ID: 32776725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.
    Fan G; Qin X; Streblow DN; Hoyos CM; Hansel DE
    Microbiol Spectr; 2021 Sep; 9(1):e0006221. PubMed ID: 34431689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Study Comparing Deep Throat Saliva With Other Respiratory Tract Specimens in the Diagnosis of Novel Coronavirus Disease 2019.
    Lai CKC; Chen Z; Lui G; Ling L; Li T; Wong MCS; Ng RWY; Tso EYK; Ho T; Fung KSC; Ng ST; Wong BKC; Boon SS; Hui DSC; Chan PKS
    J Infect Dis; 2020 Oct; 222(10):1612-1619. PubMed ID: 32738137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing Nasopharyngeal Swab and Early Morning Saliva for the Identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Rao M; Rashid FA; Sabri FSAH; Jamil NN; Zain R; Hashim R; Amran F; Kok HT; Samad MAA; Ahmad N
    Clin Infect Dis; 2021 May; 72(9):e352-e356. PubMed ID: 32761244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.